Beiersdorf is the famous Corporate Investor, which was founded in 1882. The main office of represented Corporate Investor is situated in the Hamburg. The company was established in Europe in Germany.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Beiersdorf, startups are often financed by CG Health Ventures. The meaningful sponsors for the fund in investment in the same round are investiere | Verve Capital Partners, Johnson & Johnson Innovation u2013 JJDC.
The top activity for fund was in 2019. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Health Care, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight S-Biomedic.
Related Funds
Fund Name | Location |
31Ventures Global Innovation Fund | Chiyoda, Japan |
AE Ventures | Easton, Massachusetts, United States |
Ark Angels Activator Fund | Belgium, Hasselt, Limburg |
Athos Group | Irving, Texas, United States |
Backed VC | England, London, United Kingdom |
CBC Group | Japan, Tokyo |
FSD Africa | Kenya, Nairobi, Nairobi Area |
GCI | United States, Waukesha, Wisconsin |
Madison Alley Global Ventures | New York, New York, United States |
Mountain Pine Capital | Central, Central Region, Singapore |
PTT Oil and Retail Business Public Company | Bangkok, Krung Thep, Thailand |
RBO Ventures | California, Santa Monica, United States |
Royalty Pharma | New York, New York, United States |
Stratus Ventures | Illinois, Northbrook, United States |
Teide Capital | - |
TopMonks Startup Studio | Czech Republic, Prague, Prague |
Westpool Investment Trust | England, London, United Kingdom |
Zhidian Touzi | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
DePoly | $13M | 27 Jun 2023 | Wallis, Switzerland | ||
Dermanostic | $2M | 11 Jan 2022 | Düsseldorf, Nordrhein-Westfalen, Germany | ||
Routinely | 20 May 2020 | Amsterdam, Noord-Holland, The Netherlands | |||
S-Biomedic | $4M | 18 Jul 2018 | Wisconsin, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
DePoly | $13M | 27 Jun 2023 | Wallis, Switzerland | ||
Dermanostic | $2M | 11 Jan 2022 | Düsseldorf, Nordrhein-Westfalen, Germany | ||
Routinely | 20 May 2020 | Amsterdam, Noord-Holland, The Netherlands | |||
S-Biomedic | $4M | 18 Jul 2018 | Wisconsin, United States |